Other solute carrier family mediators of the carnitine shuttle might be of interest to investigating in HR+ breast cancer, including OCTN2 and MCT9, given that the expression of these genes is strongly estrogen dependent or correlated with estrogen and/or ER expression [191,192,193]. Here, ESR1 is linked to breast cancer.